Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 24, 2022

Optimizing the screening of alpha-1 antitrypsin deficiency using serum protein electrophoresis

  • Loris Wauthier ORCID logo EMAIL logo , Stéphanie Jacques , Joris Delanghe ORCID logo and Julien Favresse

Abstract

Objectives

Alpha-1 antitrypsin (A1AT) deficiency was first identified in patients with emphysema by the absence of the α1 band on serum protein electrophoresis (SPE). Today, capillary zone electrophoresis is widely performed in laboratories. Here, we compared two SPE systems to detect decreased A1AT concentrations to optimize their use as a screening tool for A1AT deficiency.

Methods

Serum protein electrophoresis was performed on 200 samples on the Capillarys 2 and the V8 Nexus. The latter presents two α1 bands (α1 band 1 and 2) while the Capillarys 2 has only one (Capillarys 2 total α1). The measures of A1AT and α1 acid glycoprotein (AAG) were performed as well as the phenotyping of M, S and Z alleles.

Results

At a A1AT cutoff of 0.80 g/L, a cutoff of 1.21 g/L using the V8 Nexus α1 band 2 corresponded to a 100% sensitivity and a 92.4% specificity while a 1.69% cutoff corresponded to a 100% sensitivity and a 92.4% specificity. The performance of the α1 band 1 was suboptimal and rather corresponded to AAG. On the Capillarys 2, a cutoff of 2.0 g/L corresponded to a 75.0% sensitivity and a 86.6% specificity, while a 3.2% cutoff showed a 96.4% sensitivity and a 67.4% specificity. The V8 Nexus α1 band 2 was the method the most correlated with A1AT (r=0.90–0.94).

Conclusions

The V8 Nexus α1 band 2 was the best predictor of A1AT deficiency, probably owing to a better resolution. The use of SPE was however unable to predict each phenotype. Phenotype or genotype studies are therefore still advisable in case of A1AT deficiency.


Corresponding author: Loris Wauthier, Department of Laboratory Medicine, Clinique Saint-Luc Bouge, 8 Rue Saint-Luc, 5000 Bouge, Namur, Belgium, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Gooptu, B, Dickens, JA, Lomas, DA. The molecular and cellular pathology of alpha(1)-antitrypsin deficiency. Trends Mol Med 2014;20:116–27. https://doi.org/10.1016/j.molmed.2013.10.007.Search in Google Scholar PubMed

2. Strnad, P, McElvaney, NG, Lomas, DA. Alpha1-Antitrypsin deficiency. N Engl J Med 2020;382:1443–55. https://doi.org/10.1056/nejmra1910234.Search in Google Scholar PubMed

3. Dietzen, DJ. Amino acids, peptides, and proteins. In: Rifai, NHA, Wittwer, CT, editors. Tietz textbook of clinical chemistry and molecular biology. St. Louis, MO: Elsevier; 2017:389–90 pp.10.1016/B978-0-12-816061-9.00013-8Search in Google Scholar

4. Rosenberg, WBT, Tanwar, S. Liver disease. In: Rifai, NHA, Wittwer, CT, editors. Tietz textbook of clinical chemistry and molecular biology. St Louis, MO: Elsevier; 2017:1384 p.Search in Google Scholar

5. Greulich, T, Vogelmeier, CF. Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis. Ther Adv Respir Dis 2016;10:72–84. https://doi.org/10.1177/1753465815602162.Search in Google Scholar PubMed PubMed Central

6. Stoller, JK, Aboussouan, LS. Alpha1-antitrypsin deficiency. Lancet 2005;365:2225–36. https://doi.org/10.1016/s0140-6736(05)66781-5.Search in Google Scholar PubMed

7. Eriksson, S. Alpha 1-antitrypsin deficiency and the liver. Acta Paediatr 1994;83:444–7. https://doi.org/10.1111/j.1651-2227.1994.tb18141.x.Search in Google Scholar PubMed

8. Molloy, K, Hersh, CP, Morris, VB, Carroll, TP, O’Connor, CA, Lasky-Su, JA, et al.. Clarification of the risk of chronic obstructive pulmonary disease in alpha1-antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med 2014;189:419–27. https://doi.org/10.1164/rccm.201311-1984oc.Search in Google Scholar

9. Laurell, CB, Eriksson, S. The electrophoretic α;1-globulin pattern of serum in α;1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132–40. https://doi.org/10.3109/15412555.2013.771956.Search in Google Scholar PubMed

10. Sharp, HL, Bridges, RA, Krivit, W, Freier, EF. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 1969;73:934–9.Search in Google Scholar

11. Blanco, I, Diego, I, Bueno, P, Perez-Holanda, S, Casas-Maldonado, F, Miravitlles, M. Prevalence of alpha1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review. Eur Respir Rev 2020;29. https://doi.org/10.1183/16000617.0014-2020.Search in Google Scholar PubMed PubMed Central

12. American Thoracic S, European Respiratory S. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 2003;168:818–900.10.1164/rccm.168.7.818Search in Google Scholar PubMed

13. Miravitlles, M, Dirksen, A, Ferrarotti, I, Koblizek, V, Lange, P, Mahadeva, R, et al.. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in alpha1-antitrypsin deficiency. Eur Respir J 2017;50. https://doi.org/10.1183/13993003.00610-2017.Search in Google Scholar PubMed

14. Balderacchi, AM, Barzon, V, Ottaviani, S, Corino, A, Zorzetto, M, Wencker, M, et al.. Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency. Clin Chem Lab Med 2021;59:1384–91. https://doi.org/10.1515/cclm-2020-1881.Search in Google Scholar PubMed

15. Morrison, T, Booth, RA, Hauff, K, Berardi, P, Visram, A. Laboratory assessment of multiple myeloma. Adv Clin Chem 2019;89:1–58.10.1016/bs.acc.2018.12.001Search in Google Scholar PubMed

16. Scarlata, S, Santangelo, S, Ferrarotti, I, Corsico, AG, Ottaviani, S, Finamore, P, et al.. Electrophoretic alpha1-globulin for screening of alpha1-antitrypsin deficient variants. Clin Chem Lab Med 2020;58:1837–45. https://doi.org/10.1515/cclm-2020-0071.Search in Google Scholar PubMed

17. Ferrarotti, I, Poplawska-Wisniewska, B, Trevisan, MT, Koepke, J, Dresel, M, Koczulla, R, et al.. How can we improve the detection of alpha1-antitrypsin deficiency? PLoS One 2015;10:e0135316. https://doi.org/10.1371/journal.pone.0135316.Search in Google Scholar PubMed PubMed Central

18. Miravitlles, M, Torrella, M, Vidal, R, Jardí, R, Rodríguez-Frías, F, Pelegrí, D. Utilidad de la cuantífícación de la banda alfa-1 del proteinograma sérico en el cribado del déficit de alfa-1-antitripsina. Arch Bronconeumol 1998;34:536–40. https://doi.org/10.1016/s0300-2896(15)30335-5.Search in Google Scholar PubMed

19. Gay-Bellile, C, Bengoufa, D, Houze, P, Le Carrer, D, Benlakehal, M, Bousquet, B, et al.. Automated multicapillary electrophoresis for analysis of human serum proteins. Clin Chem 2003;49:1909–15. https://doi.org/10.1373/clinchem.2003.017756.Search in Google Scholar PubMed

20. Favresse, J, Yolande, L, Gras, J. Evaluation of a capillary electrophoresis system for the separation of proteins. J Appl Lab Med 2021;6:1611–7. https://doi.org/10.1093/jalm/jfab044.Search in Google Scholar PubMed

21. Rifai, NCRWK, Young, I, Burnham, CAD, Wittwer, CT, editors. Section II – Analytical techniques, Textbook of Laboratory Medicine. St. Louis, MO: Elsevier; 2022.Search in Google Scholar

22. Donato, LJ, Jenkins, SM, Smith, C, Katzmann, JA, Snyder, MR. Reference and interpretive ranges for alpha(1)-antitrypsin quantitation by phenotype in adult and pediatric populations. Am J Clin Pathol 2012;138:398–405. https://doi.org/10.1309/ajcpmeejk32acyfp.Search in Google Scholar PubMed

23. Whicher, JT, Ritchie, RF, Johnson, AM, Baudner, S, Bienvenu, J, Blirup-Jensen, S, et al.. New international reference preparation for proteins in human serum (RPPHS). Clin Chem 1994;40:934–8. https://doi.org/10.1093/clinchem/40.6.934.Search in Google Scholar

24. Zerimech, F, Hennache, G, Bellon, F, Barouh, G, Jacques Lafitte, J, Porchet, N, et al.. Evaluation of a new Sebia isoelectrofocusing kit for alpha 1-antitrypsin phenotyping with the Hydrasys System. Clin Chem Lab Med 2008;46:260–3. https://doi.org/10.1515/cclm.2008.036.Search in Google Scholar PubMed

25. Bossuyt, X. Advances in serum protein electrophoresis. Adv Clin Chem 2006;42:43–80. https://doi.org/10.1016/s0065-2423(06)42002-3.Search in Google Scholar PubMed

26. Favresse, J, Delanghe, J. High-resolution capillary electrophoresis for the determination of carbamylated albumin. Clin Chem Lab Med 2022;60:229–34. https://doi.org/10.1515/cclm-2021-0926.Search in Google Scholar PubMed

27. Slev, PR, Williams, BG, Harville, TO, Ashwood, ER, Bornhorst, JA. Efficacy of the detection of the alpha1-antitrypsin “Z” deficiency variant by routine serum protein electrophoresis. Am J Clin Pathol 2008;130:568–72. https://doi.org/10.1309/jwewe4qrqkj5ejeu.Search in Google Scholar PubMed

28. Bornhorst, JA, Greene, DN, Ashwood, ER, Grenache, DG. alpha1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest 2013;143:1000–8. https://doi.org/10.1378/chest.12-0564.Search in Google Scholar PubMed

29. Gorrini, M, Ferrarotti, I, Lupi, A, Bosoni, T, Mazzola, P, Scabini, R, et al.. Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. Clin Chem 2006;52:899–901. https://doi.org/10.1373/clinchem.2005.062059.Search in Google Scholar PubMed

30. Greulich, T, Averyanov, A, Borsa, L, Rozborilova, E, Vaicius, D, Major, T, et al.. European screening for alpha1 -antitrypsin deficiency in subjects with lung disease. Clin Respir J 2015;11:90–7. https://doi.org/10.1111/crj.12310.Search in Google Scholar PubMed

31. Janciauskiene, SM, Bals, R, Koczulla, R, Vogelmeier, C, Kohnlein, T, Welte, T. The discovery of alpha1-antitrypsin and its role in health and disease. Respir Med 2011;105:1129–39. https://doi.org/10.1016/j.rmed.2011.02.002.Search in Google Scholar PubMed

32. Ottaviani, S, Gorrini, M, Scabini, R, Kadija, Z, Paracchini, E, Mariani, F, et al.. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res 2011;157:332–8. https://doi.org/10.1016/j.trsl.2010.12.014.Search in Google Scholar PubMed

33. Lisowska-Myjak, B. AAT as a diagnostic tool. Clin Chim Acta 2005;352:1–13. https://doi.org/10.1016/j.cccn.2004.03.012.Search in Google Scholar PubMed

34. Ritchie, RF, Palomaki, GE, Neveux, LM, Navolotskaia, O. Reference distributions for the positive acute phase proteins, alpha1-acid glycoprotein (orosomucoid), alpha1-antitrypsin, and haptoglobin: a comparison of a large cohort to the world’s literature. J Clin Lab Anal 2000;14:265–70. https://doi.org/10.1002/1098-2825(20001212)14:6<265::aid-jcla3>3.0.co;2-a.10.1002/1098-2825(20001212)14:6<265::AID-JCLA3>3.0.CO;2-ASearch in Google Scholar

35. Cronin, T, Rasheed, E, Naughton, A, McElvaney, NG, Carroll, TP, Crowley, VEF, et al.. Serendipitous detection of alpha1-antitrypsin deficiency: a single institution’s experience over a 32 month period. Clin Chem Lab Med 2021;59:e293–5. https://doi.org/10.1515/cclm-2020-1750.Search in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2022-0967).


Received: 2022-09-27
Accepted: 2022-11-10
Published Online: 2022-11-24
Published in Print: 2023-02-23

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2022-0967/html
Scroll to top button